{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:49:10Z","timestamp":1784328550495,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["15-13-00017"],"award-info":[{"award-number":["15-13-00017"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.virol.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T22:58:03Z","timestamp":1535324283000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity"],"prefix":"10.1016","volume":"524","author":[{"given":"Vladimir V.","family":"Zarubaev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina A.","family":"Pushkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia S.","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia V.","family":"Galochkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica V.","family":"Garshinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Shtro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Egorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia S.","family":"Sokolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey L.","family":"Khursan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Yarovaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman F.","family":"Salakhutdinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.08.011_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.virusres.2016.11.032","article-title":"Biological fitness and natural selection of amantadine resistant variants of avian influenza H5N1 viruses","volume":"228","author":"Abdelwhab","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2018.08.011_bib2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations","volume":"49","author":"Abed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2018.08.011_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/acsinfecdis.6b00194","article-title":"Molecular mechanism underlying the action of influenza A virus fusion inhibitor MBX2546","volume":"3","author":"Basu","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virol.2018.08.011_bib4","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1128\/JVI.00140-10","article-title":"Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors","volume":"84","author":"B\u00f6ttcher-Friebertshauser","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature08722","article-title":"Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers","volume":"463","author":"Cady","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.08.011_bib6","unstructured":"CDC, 2018. Influenza Antiviral Drug Resistance. Available at \u3008https:\/\/www.cdc.gov\/flu\/about\/qa\/antiviralresistance.htm\u3009."},{"key":"10.1016\/j.virol.2018.08.011_bib7","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1038\/ncomms5794","article-title":"Generation and characterization of influenza A viruses with altered polymerase fidelity","volume":"3","author":"Cheung","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2018.08.011_bib8","first-page":"1","article-title":"Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP) 2008","volume":"57","author":"Fiore","year":"2008","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.virol.2018.08.011_bib9","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1126\/science.1093155","article-title":"The structure and receptor binding properties of the 1918 influenza hemagglutinin","volume":"303","author":"Gamblin","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.virol.2018.08.011_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcv.2011.11.002","article-title":"Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09","volume":"53","author":"G\u00edria","year":"2012","journal-title":"J. Clin. Virol."},{"issue":"12","key":"10.1016\/j.virol.2018.08.011_bib11","doi-asserted-by":"crossref","first-page":"e1003774","DOI":"10.1371\/journal.ppat.1003774","article-title":"Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice","volume":"9","author":"Hatesuer","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.08.011_bib12","first-page":"119","article-title":"Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine","volume":"176","author":"Hayden","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"12","key":"10.1016\/j.virol.2018.08.011_bib13","doi-asserted-by":"crossref","first-page":"e29778","DOI":"10.1371\/journal.pone.0029778","article-title":"Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus","volume":"6","author":"Hoopes","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2018.08.011_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IDR.S105473","article-title":"Drug resistance in influenza A virus: the epidemiology and management","volume":"10","author":"Hussain","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.virol.2018.08.011_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jiac.2015.05.004","article-title":"In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013\u20132014 season","volume":"21","author":"Ikematsu","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.virol.2018.08.011_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/irv.12046","article-title":"Clinical use of approved influenza antivirals: therapy and prophylaxis","volume":"7","author":"Ison","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.virol.2018.08.011_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2012.09.013","article-title":"Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection","volume":"96","author":"Lee","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2018.08.011_bib19","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.3390\/v7092850","article-title":"Clinical implications of antiviral resistance in influenza","volume":"7","author":"Li","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2018.08.011_bib20","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1128\/JVI.76.11.5380-5386.2002","article-title":"In vitro selection and characterization of influenza A (A\/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675","volume":"76","author":"Molla","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib21","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1038\/nmicrobiol.2017.88","article-title":"Attenuation of RNA viruses by redirecting their evolution in sequence space","volume":"2","author":"Moratorio","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virol.2018.08.011_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.antiviral.2007.12.010","article-title":"PA subunit of RNA polymerase as a promising target for anti-influenza virus agents","volume":"78","author":"Nakazawa","year":"2008","journal-title":"Antivir. Res."},{"issue":"11","key":"10.1016\/j.virol.2018.08.011_bib23","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2018.08.011_bib24","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/JVI.02077-15","article-title":"The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses","volume":"90","author":"P\u00e9cheur","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2018.08.011_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchromb.2016.10.009","article-title":"Development and validation of ultrafast LC\u2013MS\/MS method for quantification of anti-influenza agent camphecene in whole rat blood using dried blood spots and its application to pharmacokinetic studies","volume":"1036\u20131037","author":"Rogachev","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.virol.2018.08.011_bib27","first-page":"D271","article-title":"The RCSB protein data bank: integrative view of protein, gene and 3D structural information","volume":"45","author":"Rose","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2018.08.011_bib28","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"Russell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.virol.2018.08.011_bib29","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1128\/JVI.03677-13","article-title":"The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses","volume":"88","author":"Sakai","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2018.08.011_bib31","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanju\u00e1n","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(97)00061-2","article-title":"How to overcome resistance of influenza A viruses against adamantane derivatives","volume":"37","author":"Scholtissek","year":"1998","journal-title":"Antivir. Res."},{"issue":"S 2","key":"10.1016\/j.virol.2018.08.011_bib33","first-page":"S149","article-title":"Novel hemagglutinin-based influenza virus inhibitors","volume":"5","author":"Shen","year":"2013","journal-title":"J. Thorac. Dis."},{"issue":"7450","key":"10.1016\/j.virol.2018.08.011_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12118","article-title":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection","volume":"497","author":"Shirey","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.08.011_bib35","unstructured":"Small-Molecule Drug Discovery Suite 2017-3, 2017. Schr\u00f6dinger, LLC, New York, NY. \u3008https:\/\/www.schrodinger.com\/suites\/small-molecule-drug-discovery-suite\u3009."},{"key":"10.1016\/j.virol.2018.08.011_bib36","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.bmc.2014.02.038","article-title":"Camphor-based symmetric diimines as inhibitors of influenza virus reproduction","volume":"22","author":"Sokolova","year":"2014","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.virol.2018.08.011_bib37","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1016\/j.bmc.2013.08.014","article-title":"New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity","volume":"21","author":"Sokolova","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virol.2018.08.011_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejmech.2016.10.035","article-title":"Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1","volume":"127","author":"Sokolova","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virol.2018.08.011_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejmech.2015.10.010","article-title":"Discovery of a new class of antiviral compounds: camphor imine derivatives","volume":"105","author":"Sokolova","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.virol.2018.08.011_bib40","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/JVI.03799-13","article-title":"TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice","volume":"88","author":"Tarnow","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib41","doi-asserted-by":"crossref","first-page":"16199","DOI":"10.1038\/nmicrobiol.2016.199","article-title":"An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability","volume":"2","author":"van Gils","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virol.2018.08.011_bib42","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/JVI.02325-09","article-title":"Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin","volume":"84","author":"Vanderlinden","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.08.011_bib43","doi-asserted-by":"crossref","first-page":"e00081","DOI":"10.1128\/mBio.00081-15","article-title":"Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients","volume":"6","author":"Watanabe","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.virol.2018.08.011_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nyas.12462","article-title":"Continuing challenges in influenza","volume":"1323","author":"Webster","year":"2014","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.virol.2018.08.011_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2015.06.004","article-title":"Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo","volume":"120","author":"Zarubaev","year":"2015","journal-title":"Antivir. Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218302526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218302526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:47:11Z","timestamp":1758588431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218302526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":45,"alternative-id":["S0042682218302526"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.08.011","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}